146 related articles for article (PubMed ID: 32056186)
21. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma.
Ma X; Zhao K; Guo W; Yang S; Zhu X; Xiang J; Zhang Y; Li H
Ann Surg Oncol; 2015 Feb; 22(2):624-9. PubMed ID: 25155397
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
[TBL] [Abstract][Full Text] [Related]
23. Macroscopic Examination of Surgical Specimen of Esophageal Squamous Cell Carcinoma.
Lam AK
Methods Mol Biol; 2020; 2129():33-46. PubMed ID: 32056168
[TBL] [Abstract][Full Text] [Related]
24. MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma.
Minami T; Yuasa N; Miyake H; Takeuchi E; Nagai H; Ito M; Kiriyama A; Miyata K
Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29272372
[TBL] [Abstract][Full Text] [Related]
25. Anesthetic Management for Squamous Cell Carcinoma of the Esophagus.
Chan EYF; Ip DKY; Irwin MG
Methods Mol Biol; 2020; 2129():359-383. PubMed ID: 32056190
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
[TBL] [Abstract][Full Text] [Related]
27. The management of mid & proximal oesophageal squamous cell carcinoma.
Wong I; Law S
Best Pract Res Clin Gastroenterol; 2018; 36-37():85-90. PubMed ID: 30551861
[TBL] [Abstract][Full Text] [Related]
28. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
[TBL] [Abstract][Full Text] [Related]
29. Mass Spectrometry for Biomarkers Discovery in Esophageal Squamous Cell Carcinoma.
Islam F; Gopalan V; Lam AK
Methods Mol Biol; 2020; 2129():259-268. PubMed ID: 32056183
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic Diagnosis and Treatment of Esophageal Squamous Cell Carcinoma.
Zhang R; Lau LHS; Wu PIC; Yip HC; Wong SH
Methods Mol Biol; 2020; 2129():47-62. PubMed ID: 32056169
[TBL] [Abstract][Full Text] [Related]
31. Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.
Cheng N; Liu Y; Zhao G; Xu Y; Zhang T; Chen Y; Yan G; Hu Y; Yao S; Wang Z; Wang C; Chen Z; Hu Z; Liu D; Chen T
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):340-348. PubMed ID: 31655197
[TBL] [Abstract][Full Text] [Related]
32. Cervical esophageal cancer: a gap in cancer knowledge.
Hoeben A; Polak J; Van De Voorde L; Hoebers F; Grabsch HI; de Vos-Geelen J
Ann Oncol; 2016 Sep; 27(9):1664-74. PubMed ID: 27117535
[TBL] [Abstract][Full Text] [Related]
33. Surgical resection of hypopharynx and cervical esophageal cancer with a history of esophagectomy for thoracic esophageal cancer.
Ida S; Morita M; Hiyoshi Y; Ikeda K; Ando K; Kimura Y; Saeki H; Oki E; Kusumoto T; Yoshida S; Nakashima T; Watanabe M; Baba H; Maehara Y
Ann Surg Oncol; 2014 Apr; 21(4):1175-81. PubMed ID: 24380922
[TBL] [Abstract][Full Text] [Related]
34. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
35. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
36. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
[TBL] [Abstract][Full Text] [Related]
37. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
38. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
Huang PM; Hsu FM; Lin CC; Hsu CH; Cheng JC; Lee JM
Dig Surg; 2018; 35(2):104-110. PubMed ID: 28675905
[TBL] [Abstract][Full Text] [Related]
39. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients.
Chen CY; Li CC; Chien CR
World J Surg Oncol; 2018 Jul; 16(1):141. PubMed ID: 30007409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]